Ivermectin Product Registration

Ivermectin Product Registration Guide for Importers & Distributors

🌐 Introduction

Planning to import or distribute Ivermectin in your country? Whether you’re a pharmacy chain, hospital group, or government health buyer, registration is often required by the Ministry of Health (MOH) or national regulatory authorities.

Ivermectin product registration is governed by the national medicines regulatory authority in the destination market. Importers and pharmaceutical distributors may need to obtain marketing authorization before a medicinal product can be commercially supplied, while the exact application route, dossier format, documentation and local requirements vary by country.

This guide provides a general framework for understanding ivermectin product registration, including common dossier components, regulatory documentation, packaging and labeling considerations, and examples of country-specific requirements. It should not be treated as a substitute for the current guidance issued by the relevant national regulatory authority.


📄Common Documents Used in Ivermectin Product Registration

To register Ivermectin in most countries, you’ll typically need:

  1. Product Dossier (CTD format) – full technical file including:
    • Manufacturing process
    • Quality specifications
    • Clinical & stability data
    • Packaging inserts/labels
  2. WHO-GMP or EU-GMP Certificate – issued by drug control authorities
  3. Certificate of Pharmaceutical Product (COPP) – in WHO format
  4. Free Sale Certificate (FSC) – showing legal sale in home country (India)
  5. Certificate of Analysis (CoA) – batch-specific test results
  6. Product Sample – for lab testing (often required by MOH)
  7. Power of Attorney (if using local agent)

🌍 Country-Specific Requirements (Examples)

Why Country-Specific Verification Matters

Pharmaceutical registration requirements can change based on the regulatory authority, dosage form, strength, therapeutic indication, applicant status, manufacturing source and regulatory pathway. Importers should therefore confirm the current requirements directly with the national medicines regulatory authority before preparing a submission.

Some regulators also provide reliance or collaborative pathways that can affect the registration process. Tanzania, for example, currently publishes guidance on regulatory reliance for marketing authorization of human medicinal products.

CountryMOH RequirementNotes
NamibiaDossier, COPP, WHO-GMP, SamplesImport permit may be issued without full registration for NGOs
GhanaCTD Dossier, FSC, CoARequires in-country lab testing
TanzaniaOnline TMDA submission + samplesNew fast-track options for essential drugs
LebanonCOPP, Arabic labelsLocal agent or distributor mandatory
TrinidadCARPHA approval neededShared regulation with Caribbean nations

What Is a CTD Pharmaceutical Dossier?

Many medicines regulatory authorities structure marketing-authorization applications around the Common Technical Document (CTD). The CTD generally organizes information into administrative information, summaries, quality, non-clinical and clinical sections, although national requirements may differ.

Product Registration vs Import Permission: What’s the Difference?

Product registration or marketing authorization generally concerns whether a medicinal product is authorized for the relevant market. Import permits, licenses and customs documentation address whether a specific shipment can legally enter the country.

These processes are not necessarily interchangeable. An importer should determine whether the destination country requires prior marketing authorization, an import permit, both, or another regulatory pathway.


🧰 Do You Need to Register for Every Use?

Not always. Some countries allow:

  • Import Permit without full registration (for institutional use)
  • Special Access Scheme (SAS) or Named Patient Use

But full registration is needed for:

  • Retail pharmacy sale
  • Public hospital supply
  • Government tenders

📦 Packaging & Labeling for Registration

Product labeling normally needs to be consistent with the information approved or submitted to the relevant regulatory authority. Depending on the destination market, requirements may include:

  • Product name and strength
  • Active ingredient
  • Dosage form
  • Batch/lot number
  • Manufacturing and expiry dates
  • Manufacturer information
  • Storage conditions
  • Country-specific language requirements
  • Regulatory identification or registration information where applicable
  • Approved patient information / package insert where required

And importantly: Do not finalize commercial artwork before confirming the destination country’s labeling requirements.

What Importers Should Confirm Before Starting Registration

Checklist:

1. Is the product already registered in the destination market?

2. Who will be the Marketing Authorization Holder?

3. Does the country require a local applicant or representative?

4. What dossier format is accepted?

5. Is CPP/COPP required?

6. What GMP evidence is required?

7. Are product samples required?

8. What stability data are required?

9. What language must the artwork use?

10. Is bioequivalence or additional clinical documentation required?


🤝 Globalstar Registration Support Services

How Globalstar Supports Pharmaceutical Registration Projects

Globalstar Company works with established pharmaceutical manufacturing partners in India to support international pharmaceutical sourcing, contract manufacturing and export projects.

Depending on the destination market and project scope, we can coordinate with the relevant manufacturing partner regarding:

  • Product dossiers and technical documentation
  • GMP and manufacturing documentation
  • COA and product specifications
  • Stability documentation, where available
  • Packaging and labeling requirements
  • Samples and documentation for regulatory submission
  • Private-label / contract manufacturing requirements
  • Export documentation and shipment coordination

Regulatory submissions remain subject to the requirements and approval of the relevant national medicines regulatory authority.


📞 Need Ivermectin for Your Country?

Globalstar is a leading exporter of WHO-GMP certified Ivermectin tablets.
We support qualified pharmaceutical importers and distributors with product sourcing, documentation coordination, contract manufacturing and export requirements for international markets.

📩 Email: info@globalstarco.com
🌐 Website: www.globalstarco.com

Verify your Iverstar 12 product here: Check Code GS-IVM-12-2506B2

Leave a Comment

Your email address will not be published. Required fields are marked *